Feedback on 85% Rebate for MBS Item 18379 In 2025, the Department of Health and Aged Care removed the 85% rebate level for several procedural items. This followed a review which deemed certain procedures should be performed only in hospital or a hospital equivalent setting.USANZ and ANZAUS advocated that the 85% rebate for certain items be reinstated. As part of this process, ANZAUS is seeking Member feedback on Item 18379, as performed outside of a hospital or hospital-equivalent setting. Item 18379 refers to Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), intravesical injection of, with cystoscopy, for the treatment of urinary incontinence.For additional information on the 85% rebate, access the Department's Guidance on Claiming 75 / 85 / 100% Benefits Under Medicare.Please complete the brief survey below to help inform ANZAUS's response to the Department. Question Title * 1. Do you perform item 18379 outside of a hospital or hospital-equivalent (e.g. Day Surgery) setting (e.g. in rooms)? Yes No Question Title * 2. If so, how many times per year would you perform the procedure? Question Title * 3. If not, do you envisage ever performing this procedure out of a hospital or a hospital-equivalent setting? Done